Currently, regenerative medicine targeted at dogs is being conducted as free medical treatment that can be carried out after acquiring the owner’s approval, and the number of cases is increasing. As a consequence, Japan’s veterinarian association and the Ministry of Agriculture, Forestry and Fisheries (MAFF) are preparing guidelines on the use of regenerative medicines by veterinarians and companies such as Dainippon Sumitomo Co., formulated as Guidelines on guaranteeing the quality and safety of animal cell processed products (homologous origin””

Lecture of Nobuo Sasaki at 16th Annual Meeting of the Japanese Society for Regenerative Medicine